Alexander Y Pantelyat
Overview
Explore the profile of Alexander Y Pantelyat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jang Y, Oh S, Hall A, Zhang Z, Tropea T, Chen-Plotkin A, et al.
Clin Proteomics
. 2024 Sep;
21(1):56.
PMID: 39342078
Background: Progressive supranuclear palsy (PSP) is a neurodegenerative disorder often misdiagnosed as Parkinson's Disease (PD) due to shared symptoms. PSP is characterized by the accumulation of tau protein in specific...
2.
Stenum J, Hsu M, Pantelyat A, Roemmich R
PLOS Digit Health
. 2024 Mar;
3(3):e0000467.
PMID: 38530801
Gait dysfunction is common in many clinical populations and often has a profound and deleterious impact on independence and quality of life. Gait analysis is a foundational component of rehabilitation...
3.
Jang Y, Pletnikova O, Troncoso J, Pantelyat A, Dawson T, Rosenthal L, et al.
Mol Cell Proteomics
. 2023 Jun;
22(6):100570.
PMID: 37271043
No abstract available.
4.
VandeVrede L, La Joie R, Thijssen E, Asken B, Vento S, Tsuei T, et al.
JAMA Neurol
. 2023 Apr;
80(5):495-505.
PMID: 37010841
Importance: Plasma phosphorylated tau217 (p-tau217), a biomarker of Alzheimer disease (AD), is of special interest in corticobasal syndrome (CBS) because autopsy studies have revealed AD is the driving neuropathology in...
5.
Jang Y, Pletnikova O, Troncoso J, Pantelyat A, Dawson T, Rosenthal L, et al.
Mol Cell Proteomics
. 2022 Nov;
22(1):100452.
PMID: 36423813
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra (SN) of the brain. Despite decades of studies, the...
6.
Jang Y, Thuraisamy T, Redding-Ochoa J, Pletnikova O, Troncoso J, Rosenthal L, et al.
Clin Transl Med
. 2022 Nov;
12(11):e1076.
PMID: 36354133
Background: Progressive supranuclear palsy (PSP) is a neurodegenerative disorder clinically characterized by progressive postural instability, supranuclear gaze palsy, parkinsonism, and cognitive decline caused by degeneration in specific areas of the...
7.
Scott G, Arnold M, Beach T, Gibbons C, Kanthasamy A, Lebovitz R, et al.
Front Neurol
. 2022 Feb;
12:805135.
PMID: 35173668
The Lewy Body Dementia Association (LBDA) held a virtual event, the LBDA Biofluid/Tissue Biomarker Symposium, on January 25, 2021, to present advances in biomarkers for Lewy body dementia (LBD), which...
8.
Wang E, Berninger L, Pantelyat A, Hunsberger J, Smith T
A A Pract
. 2022 Jan;
16(1):e01560.
PMID: 35050906
The management of pain in patients with multiple system atrophy (MSA) is often inadequate, and treatments commonly result in adverse effects. A 63-year-old man with the parkinsonian subtype of MSA...
9.
Padmanabhan P, Sreekanth Rao K, Gonzalez A, Pantelyat A, Chib V, Roemmich R
J Parkinsons Dis
. 2021 Sep;
11(4):2073-2084.
PMID: 34511512
Background: Gait slowing is a common feature of Parkinson's disease (PD). Many therapies aim to improve gait speed in persons with PD, but goals are often imprecise. How fast should...
10.
Sun Y, Li C, Hui Q, Huang Y, Barbano R, Rodriguez R, et al.
Mov Disord
. 2021 Jul;
36(12):2795-2801.
PMID: 34320236
Background: Several monogenic causes for isolated dystonia have been identified, but they collectively account for only a small proportion of cases. Two genome-wide association studies have reported a few potential...